DOI: 10.22270/jmpas.V10I1.980
VOLUME - 10 ISSUE - 1 JANUARY-FEBRUARY 2021
Das Somnath*, Chatterjee Gobinda, Nayak Parthasarathi, Prakash Aishwarya, Rudra Olympia,
Mandal Aniruddha
Institute of Post Graduate Medical Education and Research (IGPMER), Kolkata, West Bengal, India
ABSTRACT
Fixed drug eruption (FDE) is a cutaneous adverse drug reaction characterized by recurrent well‐defined lesions occurring in the same sites each time the offending drug is taken. FDEs account for 4–39% of all drug eruptions. Commonly affected sites include the lips, genitals, palms, and soles. Typically, FDE presents as a sharply‐defined, round or oval erythematous and oedematous plaque which evolves to become dusky, violaceous, and occasionally vesicular or bullous. Giant bullous variant is an uncommon manifestation of FDE
Keywords:
Fixed drug eruption, Giant bullous FDE, Systemic lupus erythematous, Mefenamic acid, Bullous eruption